Trial intelligence / Profile preview

Giomer Varnish vs Fluoride Varnish for White Spot Lesions

NCT05775250Completed

Sponsor
October University for Modern Sciences and Arts
Start
Mar 2023
Primary completion
Oct 2023
Modality
Implantable Devices
Countries
1
01

Overview

Randomised trial of giomer varnish in White spot lesion (WSL) (2 arms), sponsored by October University for Modern Sciences and Arts. Primary endpoint: White spot lesion color change at 6 months. Started Mar 2023; status: completed.

02

Drugs

giomer varnish
03

Conditions

White spot lesion (WSL)

Beyond the preview

Go deeper on NCT05775250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05775250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call